These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31689309)

  • 1. Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
    Tapia F; Wohlfarth D; Sandig V; Jordan I; Genzel Y; Reichl U
    PLoS One; 2019; 14(11):e0224317. PubMed ID: 31689309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Gränicher G; Coronel J; Pralow A; Marichal-Gallardo P; Wolff M; Rapp E; Karlas A; Sandig V; Genzel Y; Reichl U
    Vaccine; 2019 Nov; 37(47):7019-7028. PubMed ID: 31005427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.
    Genzel Y; Vogel T; Buck J; Behrendt I; Ramirez DV; Schiedner G; Jordan I; Reichl U
    Vaccine; 2014 May; 32(24):2770-81. PubMed ID: 24583003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of an acoustic settler versus a hollow fiber-based ATF technology for influenza virus production in perfusion.
    Gränicher G; Coronel J; Trampler F; Jordan I; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4877-4888. PubMed ID: 32291490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
    Coronel J; Behrendt I; Bürgin T; Anderlei T; Sandig V; Reichl U; Genzel Y
    Vaccine; 2019 Nov; 37(47):7011-7018. PubMed ID: 31266669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor.
    Tapia F; Vogel T; Genzel Y; Behrendt I; Hirschel M; Gangemi JD; Reichl U
    Vaccine; 2014 Feb; 32(8):1003-11. PubMed ID: 24269322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.
    Frensing T; Heldt FS; Pflugmacher A; Behrendt I; Jordan I; Flockerzi D; Genzel Y; Reichl U
    PLoS One; 2013; 8(9):e72288. PubMed ID: 24039749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
    Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
    Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor.
    Sun B; Yu X; Kong W; Sun S; Yang P; Zhu C; Zhang H; Wu Y; Chen Y; Shi Y; Zhang X; Jiang C
    Appl Microbiol Biotechnol; 2013 Feb; 97(3):1063-70. PubMed ID: 22945265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production.
    Bissinger T; Fritsch J; Mihut A; Wu Y; Liu X; Genzel Y; Tan WS; Reichl U
    Vaccine; 2019 Nov; 37(47):7003-7010. PubMed ID: 31047676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells.
    Wu Y; Bissinger T; Genzel Y; Liu X; Reichl U; Tan WS
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1421-1434. PubMed ID: 33515287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.
    Lohr V; Genzel Y; Jordan I; Katinger D; Mahr S; Sandig V; Reichl U
    BMC Biotechnol; 2012 Oct; 12():79. PubMed ID: 23110398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.
    Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U
    Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.
    Huang D; Peng WJ; Ye Q; Liu XP; Zhao L; Fan L; Xia-Hou K; Jia HJ; Luo J; Zhou LT; Li BB; Wang SL; Xu WT; Chen Z; Tan WS
    PLoS One; 2015; 10(11):e0141686. PubMed ID: 26540170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.
    Vázquez-Ramírez D; Jordan I; Sandig V; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):3025-3035. PubMed ID: 30796494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.
    Peschel B; Frentzel S; Laske T; Genzel Y; Reichl U
    Vaccine; 2013 Nov; 31(48):5693-9. PubMed ID: 24113260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbitally Shaken Single-Use Bioreactor for Animal Cell Cultivation: Fed-Batch and Perfusion Mode.
    Bürgin T; Coronel J; Hagens G; Keebler MV; Genzel Y; Reichl U; Anderlei T
    Methods Mol Biol; 2020; 2095():105-123. PubMed ID: 31858465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
    Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
    BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.
    Chu C; Lugovtsev V; Lewis A; Betenbaugh M; Shiloach J
    Vaccine; 2010 Oct; 28(44):7193-201. PubMed ID: 20800699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.
    Isken B; Genzel Y; Reichl U
    Vaccine; 2012 Jul; 30(35):5253-61. PubMed ID: 22698452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.